People

Mounjaro has been an “overwhelmingly positive experience” for PharmaDoctor’s chief executive Graham Thoms, but he stresses it’s neither a “magic bullet” nor a “short-term fix” and that uniform regulation must be implemented.

CPE data shows 96% of pharmacy owners are “concerned” or “very concerned” that “their business may not survive this winter” as Sadik Al-Hassan MP is “eager to see this government avoid mistakes made during the past 14 years that have brought our sector to a crisis point”.

The regulator has issued a year’s suspension in an “unusual case” that saw a pharmacist send prescription only medicines (POMs) “hidden in a barrel with clothes and shoes” to Sierra Leone.

The US DOJ has filed a lawsuit against CVS alleging its “actions helped to fuel the opioid crisis” as it “prioritized corporate profits over patient safety”.

Asda will “endeavour to retain as many pharmacists as possible” while it implements a “new model” – but is no longer offering £1,000 one-time payments to sweeten the deal, C+D has learned.

Ex-social-media-influencer Georgie Aldous, who was able to take weight loss jab Mounjaro despite suffering with an eating disorder, has warned followers that the drug is “not worth the risk”.

NHS England (NHSE) has decided that mandatory rotations for pharmacy trainees “will be delayed” until the 2027/28 cohort.

The proportion of students who passed this autumn’s registration exam has fallen almost 10 percentage points compared to last year, pharmacy regulators have revealed.

The PDA has released a statement in response to Superdrug management’s communication with pharmacists, which the body said was “ill informed” and in need of “correction”.

The General Pharmaceutical Council (GPhC) has found that the fitness to practice (FtP) of a pharmacist who was in charge when patient confidentiality was breached by the “fly-tipping” of medical waste in an “unsecure location” is “no longer impaired”.